Prof. Dr. med. et phil. nat. Markus Jörger
chief of service
Medizinische Onkologie und Hämatologie · Dept. I
Contact
9007 St. Gallen
Switzerland
Units
Medizinische Onkologie und Hämatologie
Profile Function
chief of service
Research Area
- Pharmacokinetics and pharmacodynamics of cancer drugs
- Pharmacogenetics and predictive markers in solid cancer patients
- Phase1- and translational trial designs
Former Positions
May 1997 - April 1998 :
Internal Medicine, Thusis, Switzerland (head: Dr. med. U.P.Veraguth)
May 1998 - May 1999 :
Neurology, Valens, Switzerland (head: Prof. Dr.med. J.Kesselring)
June 1999 – May 2000:
Internal Medicine, University Hospital Zuerich, Switzerland (head: Prof. Dr.med. F.Follath)
May 2000 – November 2001:
Oncology, University Hospital Zuerich, Switzerland (head: Prof. Dr.med. Chr.Sauter) Clinical research unter Prof. Dr.med. R.Stahel
November 2001 – July 2003:
Internal Medicine and Oncology, Kantonsspital St.Gallen, Switzerland (head: Prof.Dr.med. R. Galeazzi (Internal Medicine), Prof. Dr.med. Th. Cerny (Oncology)
August 2003 – December 2007:
Research fellow unter Prof. Dr. med. J. Schellens und Prof. J. Beijnen, Netherlands Cancer Institute, Amsterdam, The Netherlands
January 2004 – December 2006:
Clinical expert for the Dutch Branch of the European Medicines Evaluation Agency (EMEA)
January 2007 – June 2008:
Department of Oncology and Hematology, Kantonsspital St.Gallen, Switzerland, under Prof. Th. Cerny.
July 2008 – July 2009:
Senology Center of Eastern Switzerland, Kantonsspital St. Gallen, under Prof. B. Thürlimann
Awards
Medical diploma : November 1996
MD: November 1996 “Basler Befragung von Drogenabhängigen zur Medikamentengruppe der Benzodiazepine”
1-year fellowship from the "Union International Contre le Cancer" (UICC) 2002
1-year fellowship from the European Society of Medical Oncology (ESMO) 2003
1-year fellowship from the Swiss National Foundation (SNF) 2003
FMH Internal Medicine : February 1, 2007
FMH Medical Oncology : April 29, 2008
PhD: December 18, 2007, Utrecht University, The Netherlands “Pharmacokinetic and pharmacogenetic profiling in solid cancer patients”
Affiliations
1996 – present : Foederatio Medicorum Helveticorum
2001 - present : European Society of Medical Oncology
2001 - present : American Association of Cancer Research
2001 - present : American Society of Clinical Oncology
2001 - present : Flims Alumni Club